Newsroom

Sorted by: Latest
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Smart Grid Infrastructure UCITS ETF 06.01.2026 GRDU.LN IE000J80JTL1 20,800,002.00 USD 1,131,498,723.45 54.399  ...
-

ICAPE Group: H2 2025 Half Yearly Report on the Liquidity Agreement Signed With the Gilbert Dupont Brokerage Firm

FONTENAY-AUX-ROSES, France--(BUSINESS WIRE)--Regulatory News: ICAPE Group (ISIN : FR001400A3Q3 – mnemonic : ALICA) Under the liquidity agreement entered into between ICAPE Holding and the Gilbert Dupont brokerage firm, the following resources were listed in the liquidity account as of December 31, 2025: - Number of shares: 39,560 - Cash balance: €141,828.34 During the second half of 2025, volumes traded represented: BUY 34,361 shares €229,842.20 870 transactions SELL 30,478 shares €206,006.12 7...
-

ICAPE Group : Bilan semestriel S2 2025 du contrat de liquidité contracté avec la société de bourse gilbert dupont

FONTENAY-AUX-ROSES, France--(BUSINESS WIRE)--Regulatory News :  ICAPE Group (ISIN : FR001400A3Q3 – Mnémonique : ALICA) Au titre du contrat de liquidité confié par la société ICAPE HOLDING à la Société de Bourse Gilbert Dupont, à la date du 31 décembre 2025, les moyens suivants figuraient au compte de liquidité : - Nombre d’actions : 39 560 - Solde en espèces : 141 828,34 € Au cours du 2ème semestre 2025, il a été négocié un total de : ACHAT 34 361 titres 229 842,20 € 870 transactions VENTE 30 4...
-

Taco Cabana Enters 2026 with a Tasty New Chicken Wrap Combo Meal, Even More Compelling Value and Flavor-Packed Favorites

SAN ANTONIO, Texas--(BUSINESS WIRE)--Taco Cabana® is starting 2026 in a bold way with crave-worthy menu additions that bring big flavor and strong value to guests in the new year....
-

ALSAC Names Martin Hand Chief Development Officer; Welcomes Deb Garcia as Senior Vice President of Strategy

MEMPHIS, Tenn.--(BUSINESS WIRE)--ALSAC, the fundraising and awareness organization for St. Jude Children’s Research Hospital®, today announced that Martin Hand has been appointed chief development officer. In his new role, Hand leads ALSAC’s revenue-generation and development efforts, including fundraising and philanthropy, corporate partnerships, donor acquisition and retention strategies, planned giving, direct response campaigns and other revenue-driving programs. ALSAC also announced that D...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 06.01.2026 LANDXEN.LN IE000C75IMX8 22,412.00 USD 419,941.58 18.737  ...
-

BANK OF NEW YORK MELLON UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 1/6/2026 Issue ¦ Standard Chartered Bank - Series No 276 USD 21,000,000 FRN due October 2028     ISIN Number ¦ XS2701599826 ISIN Reference ¦ 270159982 Issue Nomin USD ¦ 21000000 Period ¦ 10/14/2025 to 1/13/2026   Payment Date 1/13/2026 Number of Days ¦ 91 Rate ¦ 5.18878   Denomination USD ¦ 1000   ¦ 21000000   ¦       Amount Payable per Denomination ¦ 13.12   ¦ 275520   ¦       Bank of New York    ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 06.01.2026 LANDXN.LN IE000RN036E0 28,035.00 USD 572,049.49 20.405  ...
-

SYK Inhibitors Market, Drug Price, Sales & Clinical Trials Outlook, 2030 - Rigel Pharmaceuticals Leads With Fostamatinib and Hutchmed's Sovleplenib Emerges as Late-Stage Breakthrough Candidate for ITP - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "SYK Inhibitors Market, Drug Price, Sales & Clinical Trials Outlook 2030" report has been added to ResearchAndMarkets.com's offering. Report Findings & Highlights: Global SYK Inhibitor Market Growth 2020-2024: 13% CAGR Approved SYK Inhibitor Drugs: 1 Dosage, Price & Sales Insight of Approved Drug Global Market Trend, Size & Future Opportunity Outlook Comprehensive Insight on Global SYK Inhibitors Clinical Pipeline: > 15 Drugs Global SYK Inhibitors...
-

Dr. Rasha Kelej, CEO of Merck Foundation, Named One of ‘100 Most Influential Africans 2025’ Alongside Presidents of Angola, South Africa, and Ghana by New African Magazine, UK

DUBAI, United Arab Emirates--(BUSINESS WIRE)--Dr. Rasha Kelej, CEO of Merck Foundation, has been recognized as one of the 100 Most Influential Africans by New African Magazine (UK)....